Point72 Asia (Singapore)’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$109K Sell
6,854
-17,311
-72% -$251K 0.02% 424
2025
Q2
$277K Buy
+24,165
New +$272K 0.05% 289
2025
Q1
Sell
-5,368
Closed -$90.7K 909
2024
Q4
$90.7K Buy
+5,368
New +$104K 0.02% 389
2017
Q2
Sell
-400,581
Closed -$15.4M 20
2017
Q1
$15.4M Buy
+400,581
New +$12.1M 6.31% 7
2016
Q4
Sell
-1,285,000
Closed -$20.6M 19
2016
Q3
$20.6M Buy
+1,285,000
New +$14.7M 9.33% 2

Other funds holding CC

Point72 Asia (Singapore)'s CC Position: Q3 2025 in Review

Point72 Asia (Singapore) reduced its Chemours (CC) stake by 72% in Q3 2025, selling an estimated $251K and leaving 6,854 shares worth $109K. The position accounts for 0.02% of the portfolio, ranked #424.

Point72 Asia (Singapore) first reported a position in CC in Q3 2016 and has held it in 5 quarters since. The position peaked at $20.6M in Q3 2016. 428 funds tracked by Wall St. Rank hold CC as of Q3 2025.

  • Point72 Asia (Singapore) held 6,854 shares of Chemours worth $109K as of Q3 2025.
  • Point72 Asia (Singapore) sold 17,311 Chemours shares in Q3 2025, an estimated $251K.
  • Chemours made up 0.02% of Point72 Asia (Singapore)'s portfolio in Q3 2025, its #424 holding.
  • Point72 Asia (Singapore) first reported a position in Chemours in Q3 2016 and has held it in 5 quarters since.
  • Point72 Asia (Singapore)'s Chemours position peaked at $20.6M in Q3 2016.
  • 428 funds tracked by Wall St. Rank held Chemours as of Q3 2025.

Based on Point72 Asia (Singapore)'s 13F filing for Q3 2025, filed 14 Nov 2025.